CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection. 2015

Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
Emory Vaccine Center, Department of Microbiology and Immunology, and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.

Here, we show that a CD40L-adjuvanted DNA/modified vaccinia virus Ankara (MVA) simian immunodeficiency virus (SIV) vaccine enhances protection against a pathogenic neutralization-resistant mucosal SIV infection, improves long-term viral control, and prevents AIDS. Analyses of serum IgG antibodies to linear peptides of SIV Env revealed a strong response to V2, with targeting of fewer epitopes in the immunodominant region of gp41 (gp41-ID) and the V1 region as a correlate for enhanced protection. Greater expansion of antiviral CD8 T cells in the gut correlated with long-term viral control.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D053208 Kaplan-Meier Estimate A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995) Kaplan-Meier Survival Curve,Kaplan-Meier Analysis,Kaplan-Meier Survival Curves,Kaplan-Meier Test,Product-Limit Method,Analysis, Kaplan-Meier,Curve, Kaplan-Meier Survival,Curves, Kaplan-Meier Survival,Estimate, Kaplan-Meier,Kaplan Meier Analysis,Kaplan Meier Survival Curve,Kaplan Meier Survival Curves,Kaplan Meier Test,Method, Product-Limit,Methods, Product-Limit,Product Limit Method,Product-Limit Methods,Survival Curve, Kaplan-Meier,Survival Curves, Kaplan-Meier,Test, Kaplan-Meier
D018414 CD8-Positive T-Lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes. Suppressor T-Lymphocytes, CD8-Positive,T8 Cells,T8 Lymphocytes,CD8-Positive Lymphocytes,Suppressor T-Cells, CD8-Positive,CD8 Positive Lymphocytes,CD8 Positive T Lymphocytes,CD8-Positive Lymphocyte,CD8-Positive Suppressor T-Cell,CD8-Positive Suppressor T-Cells,CD8-Positive Suppressor T-Lymphocyte,CD8-Positive Suppressor T-Lymphocytes,CD8-Positive T-Lymphocyte,Cell, T8,Cells, T8,Lymphocyte, CD8-Positive,Lymphocyte, T8,Lymphocytes, CD8-Positive,Lymphocytes, T8,Suppressor T Cells, CD8 Positive,Suppressor T Lymphocytes, CD8 Positive,Suppressor T-Cell, CD8-Positive,Suppressor T-Lymphocyte, CD8-Positive,T-Cell, CD8-Positive Suppressor,T-Cells, CD8-Positive Suppressor,T-Lymphocyte, CD8-Positive,T-Lymphocyte, CD8-Positive Suppressor,T-Lymphocytes, CD8-Positive,T-Lymphocytes, CD8-Positive Suppressor,T8 Cell,T8 Lymphocyte
D018449 SAIDS Vaccines Vaccines or candidate vaccines designed to prevent SAIDS; (SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME); and containing inactivated SIMIAN IMMUNODEFICIENCY VIRUS or type D retroviruses or some of their component antigens. SIV Vaccine,Simian AIDS Vaccines,SIV Vaccines,AIDS Vaccines, Simian,Vaccine, SIV,Vaccines, SAIDS,Vaccines, SIV,Vaccines, Simian AIDS

Related Publications

Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
September 2014, Journal of virology,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
January 2008, Vaccine,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
August 1989, Proceedings of the National Academy of Sciences of the United States of America,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
January 2016, Open forum infectious diseases,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
October 2016, Journal of virology,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
July 2011, The Journal of infectious diseases,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
April 2002, The Journal of general virology,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
March 2004, Journal of virology,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
April 2002, Journal of virology,
Suefen Kwa, and Shanmugalakshmi Sadagopal, and Xiaoying Shen, and Jung Joo Hong, and Sailaja Gangadhara, and Rahul Basu, and Blandine Victor, and Smita S Iyer, and Celia C LaBranche, and David C Montefiori, and Georgia D Tomaras, and Francois Villinger, and Bernard Moss, and Pamela A Kozlowski, and Rama Rao Amara
March 2000, Journal of virology,
Copied contents to your clipboard!